RISING PHARMACEUTICALS recalls Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 0766…
- Recall date
- February 15, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0348-2023
- FDA classification
- Class II
- Brand / firm
- RISING PHARMACEUTICALS
- Sold / distributed
- Product was distributed to 16 distributors and 8 wholesalers who may have further distributed the product nationwide.
Why it was recalled
Failed Impurities/Degradation Specifications
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01
Get recall alerts
Free email alert whenever RISING PHARMACEUTICALS has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: RISING PHARMACEUTICALS